Logo image of FONR

FONAR CORP (FONR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FONR - US3444374058 - Common Stock

18.55 USD
-0.01 (-0.05%)
Last: 1/9/2026, 8:00:00 PM
Fundamental Rating

5

Overall FONR gets a fundamental rating of 5 out of 10. We evaluated FONR against 185 industry peers in the Health Care Equipment & Supplies industry. FONR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FONR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FONR was profitable.
In the past year FONR had a positive cash flow from operations.
Each year in the past 5 years FONR has been profitable.
Each year in the past 5 years FONR had a positive operating cash flow.
FONR Yearly Net Income VS EBIT VS OCF VS FCFFONR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

1.2 Ratios

The Return On Assets of FONR (3.20%) is better than 77.84% of its industry peers.
With a decent Return On Equity value of 4.00%, FONR is doing good in the industry, outperforming 75.68% of the companies in the same industry.
FONR has a better Return On Invested Capital (3.80%) than 71.89% of its industry peers.
FONR had an Average Return On Invested Capital over the past 3 years of 5.58%. This is below the industry average of 8.84%.
Industry RankSector Rank
ROA 3.2%
ROE 4%
ROIC 3.8%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
FONR Yearly ROA, ROE, ROICFONR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

FONR's Profit Margin of 6.63% is fine compared to the rest of the industry. FONR outperforms 78.92% of its industry peers.
FONR's Profit Margin has declined in the last couple of years.
FONR's Operating Margin of 9.66% is fine compared to the rest of the industry. FONR outperforms 77.84% of its industry peers.
In the last couple of years the Operating Margin of FONR has declined.
Looking at the Gross Margin, with a value of 41.07%, FONR is doing worse than 65.95% of the companies in the same industry.
In the last couple of years the Gross Margin of FONR has declined.
Industry RankSector Rank
OM 9.66%
PM (TTM) 6.63%
GM 41.07%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
FONR Yearly Profit, Operating, Gross MarginsFONR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

FONR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
FONR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, FONR has less shares outstanding
Compared to 1 year ago, FONR has an improved debt to assets ratio.
FONR Yearly Shares OutstandingFONR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
FONR Yearly Total Debt VS Total AssetsFONR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

FONR has an Altman-Z score of 3.20. This indicates that FONR is financially healthy and has little risk of bankruptcy at the moment.
FONR has a better Altman-Z score (3.20) than 69.73% of its industry peers.
The Debt to FCF ratio of FONR is 0.05, which is an excellent value as it means it would take FONR, only 0.05 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of FONR (0.05) is better than 94.05% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, FONR is doing good in the industry, outperforming 74.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 3.2
ROIC/WACC0.39
WACC9.79%
FONR Yearly LT Debt VS Equity VS FCFFONR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

FONR has a Current Ratio of 8.62. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.62, FONR belongs to the best of the industry, outperforming 89.73% of the companies in the same industry.
A Quick Ratio of 8.46 indicates that FONR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 8.46, FONR belongs to the top of the industry, outperforming 89.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.62
Quick Ratio 8.46
FONR Yearly Current Assets VS Current LiabilitesFONR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

1

3. Growth

3.1 Past

The earnings per share for FONR have decreased strongly by -20.59% in the last year.
FONR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.90% yearly.
FONR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.36%.
Measured over the past years, FONR shows a small growth in Revenue. The Revenue has been growing by 4.02% on average per year.
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FONR Yearly Revenue VS EstimatesFONR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

FONR is valuated rather expensively with a Price/Earnings ratio of 17.84.
Compared to the rest of the industry, the Price/Earnings ratio of FONR indicates a rather cheap valuation: FONR is cheaper than 84.32% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.19. FONR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.84
Fwd PE N/A
FONR Price Earnings VS Forward Price EarningsFONR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FONR indicates a rather cheap valuation: FONR is cheaper than 97.84% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, FONR is valued cheaper than 92.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.35
EV/EBITDA 5.88
FONR Per share dataFONR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)19.8
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FONR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

FONAR CORP

NASDAQ:FONR (1/9/2026, 8:00:00 PM)

18.55

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-17 2025-11-17
Earnings (Next)02-16 2026-02-16
Inst Owners47.09%
Inst Owner Change0%
Ins Owners4.39%
Ins Owner Change0%
Market Cap136.34M
Revenue(TTM)105.43M
Net Income(TTM)6.99M
Analysts0
Price TargetN/A
Short Float %0.15%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.84
Fwd PE N/A
P/S 1.29
P/FCF 18.35
P/OCF 12.07
P/B 0.78
P/tB 0.81
EV/EBITDA 5.88
EPS(TTM)1.04
EY5.61%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.01
FCFY5.45%
OCF(TTM)1.54
OCFY8.29%
SpS14.34
BVpS23.79
TBVpS22.77
PEG (NY)N/A
PEG (5Y)19.8
Graham Number23.6
Profitability
Industry RankSector Rank
ROA 3.2%
ROE 4%
ROCE 5.05%
ROIC 3.8%
ROICexc 5.21%
ROICexgc 5.49%
OM 9.66%
PM (TTM) 6.63%
GM 41.07%
FCFM 7.05%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
ROICexc(3y)7.78%
ROICexc(5y)9.2%
ROICexgc(3y)8.22%
ROICexgc(5y)9.77%
ROCE(3y)7.41%
ROCE(5y)8.87%
ROICexgc growth 3Y-21.28%
ROICexgc growth 5Y-6.2%
ROICexc growth 3Y-21.03%
ROICexc growth 5Y-5.92%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 101.91%
Cap/Sales 3.67%
Interest Coverage 547.62
Cash Conversion 80.82%
Profit Quality 106.36%
Current Ratio 8.62
Quick Ratio 8.46
Altman-Z 3.2
F-Score5
WACC9.79%
ROIC/WACC0.39
Cap/Depr(3y)64.91%
Cap/Depr(5y)77.48%
Cap/Sales(3y)2.95%
Cap/Sales(5y)3.54%
Profit Quality(3y)114.83%
Profit Quality(5y)119.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.09%
EBIT growth 3Y-19.22%
EBIT growth 5Y-3.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32%
FCF growth 3Y-11.29%
FCF growth 5Y-10.21%
OCF growth 1Y-21.49%
OCF growth 3Y-9.7%
OCF growth 5Y-11.2%

FONAR CORP / FONR FAQ

Can you provide the ChartMill fundamental rating for FONAR CORP?

ChartMill assigns a fundamental rating of 5 / 10 to FONR.


What is the valuation status of FONAR CORP (FONR) stock?

ChartMill assigns a valuation rating of 4 / 10 to FONAR CORP (FONR). This can be considered as Fairly Valued.


Can you provide the profitability details for FONAR CORP?

FONAR CORP (FONR) has a profitability rating of 5 / 10.